Golubovskaya, V.; Sienkiewicz, J.; Sun, J.; Huang, Y.; Hu, L.; Zhou, H.; Harto, H.; Xu, S.; Berahovich, R.; Bodmer, W.;
et al. mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth. Cancers 2023, 15, 2860.
https://doi.org/10.3390/cancers15102860
AMA Style
Golubovskaya V, Sienkiewicz J, Sun J, Huang Y, Hu L, Zhou H, Harto H, Xu S, Berahovich R, Bodmer W,
et al. mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth. Cancers. 2023; 15(10):2860.
https://doi.org/10.3390/cancers15102860
Chicago/Turabian Style
Golubovskaya, Vita, John Sienkiewicz, Jinying Sun, Yanwei Huang, Liang Hu, Hua Zhou, Hizkia Harto, Shirley Xu, Robert Berahovich, Walter Bodmer,
and et al. 2023. "mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth" Cancers 15, no. 10: 2860.
https://doi.org/10.3390/cancers15102860
APA Style
Golubovskaya, V., Sienkiewicz, J., Sun, J., Huang, Y., Hu, L., Zhou, H., Harto, H., Xu, S., Berahovich, R., Bodmer, W., & Wu, L.
(2023). mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth. Cancers, 15(10), 2860.
https://doi.org/10.3390/cancers15102860